Target intelligence / Profile preview

Dystrophia myotonica WD repeat-containing protein (DMWD)

Target
DMWD
Molecular classification
WD repeat protein, Other
01

Overview

Dystrophia myotonica WD repeat-containing protein (DMWD) is a WD repeat protein encoded by the DMWD gene on human chromosome 19[11][13][14]. It functions as a regulator and cofactor in the deubiquitinating USP12/DMWD/WDR48 complex, promoting USP12 enzymatic activity[8][9][6][13]. WD repeat proteins generally act as scaffolds for multiprotein complexes, and DMWD is predominantly localized to the cytoplasm and nucleus[9][13]. The gene is located near the DMPK gene, and expanded CTG repeats in DMPK (which cause myotonic dystrophy type 1) can lead to partial silencing of neighboring genes, such as DMWD, through chromatin structural alterations[3][5][12]. DMWD is expressed developmentally and is notably abundant in synapse-dense brain regions[5]. There are currently no known approved drugs that specifically interact with DMWD, and it is not considered a direct therapeutic target at this time[9][13][11].

Other names
DMWDDM1 locus, WD repeat containingDM9DMR-N9gene59D19S593Edystrophia myotonica-containing WD repeat motif proteinprotein 59protein DMR-N9DMRN9
02

Biological functions

Deubiquitinase activator activityRegulator of deubiquitinating enzyme complexes (e.g., USP12/DMWD/WDR48)Putative scaffolding protein in protein-protein interaction
03

Disease associations

Myotonic dystrophy type 1 (DM1) region geneSpinocerebellar ataxia 40 (association)

Beyond the preview

Go deeper on Dystrophia myotonica WD repeat-containing protein (DMWD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophia myotonica WD repeat-containing protein (DMWD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call